Publications by authors named "Dirk Thye"

Claim this Profile
U
Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.
Biljana Horn, Giovanni Mambrini, Maureen Roden, Caralee Schaefer, Dirk Thye

Front Drug Deliv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATTeST trial in ataxia telangiectasia: some concerns - Authors' response.
Biljana Horn, Maureen Roden, Dirk Thye

Lancet Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia.
Mary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, Eppie M Yiu, Barbara Pietrucha, Dirk Thye

Front Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Stefan Zielen, Thomas Crawford, Luca Benatti, Mauro Magnani, Matthias Kieslich, Dirk Thye

Lancet Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.
Taylor Sandison, Voon Ong, Jonathan Lee, Dirk Thye

Antimicrob Agents Chemother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
Alena Jandourek, Alexander Smith, Lily Llorens, Dirk A Thye, Paul B Eckburg

Hosp Pract (1995)· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infections.
George H Talbot, Tanya O'Neal, Anita F Das, Dirk Thye

Antimicrob Agents Chemother· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
H David Friedland, Tanya O'Neal, Donald Biek, Paul B Eckburg, Douglas R Rank, Dirk Thye

Antimicrob Agents Chemother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases.
Arnold Louie, Mariana Castanheira, Weiguo Liu, Caroline Grasso, Ronald N Jones, Dirk Thye

Antimicrob Agents Chemother· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
Ian A Critchley, Paul B Eckburg, Alena Jandourek, Donald Biek, H David Friedland, Dirk A Thye

J Antimicrob Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Thomas M File, Donald E Low, Paul B Eckburg, George H Talbot, H David Friedland, Dirk A Thye

J Antimicrob Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Donald E Low, Thomas M File, Paul B Eckburg, George H Talbot, H David Friedland, Dirk A Thye

J Antimicrob Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
Thomas M File, Donald E Low, Paul B Eckburg, George H Talbot, H David Friedland, Dirk Thye

Clin Infect Dis· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
G Ralph Corey, Mark H Wilcox, George H Talbot, Dirk Thye, David Friedland

J Antimicrob Chemother· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Mark H Wilcox, G Ralph Corey, George H Talbot, Dirk Thye, David Friedland

J Antimicrob Chemother· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Donald Biek, Ian A Critchley, Todd A Riccobene, Dirk A Thye

J Antimicrob Chemother· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.
G Ralph Corey, Mark Wilcox, George H Talbot, H David Friedland, Tanya Baculik, Dirk Thye

Clin Infect Dis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections.
George H Talbot, Dirk Thye, Anita Das, Yigong Ge

Antimicrob Agents Chemother· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis